1 – 49 of 49
- show: 250
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2016
- Validation of the FNIH sarcopenia criteria and SOF frailty index as predictors for longterm mortality in ambulatory older men (
- Validation of the FNIH sarcopenia criteria and SOF frailty index as predictors of long-term mortality in ambulatory older men (
- Validation of the Study of Osteoporotic Fractures (SOF) frailty index as predictor of long-term mortality in ambulatory older men (
- Association of spontaneous 3-year changes in physical function with subsequent 15-year mortality in community-dwelling older men (
- Three year functional changes and long-term mortality hazard in community-dwelling older men (
- 2015
- Persistent decline over 3 years in physical function predicts 15-year mortality in ambulatory older men (
- Preservation of volumetric bone density and geometry in trans women during cross-sex hormonal therapy: a prospective observational study (
- Longitudinal performance assessment for predicting adverse outcomes: the added value to single time point Timed Up and Go assessment (
- Maternal age at childbirth is associated with glucose metabolism in adult men (
- Change in timed up and go performance over time in community-dwelling older men (
- Body composition, bone turnover, and bone mass in trans men during testosterone treatment: 1-year follow-up data from a prospective case-controlled study (ENIGI) (
- In young, healthy men, the relationship between serum osteocalcin levels and metabolic profile is mediated through fat mass (
- Frailty and health-related quality of life in ambulatory older men (
- Change in Timed Up and Go performance over time in community-dwelling older men (
- The FNIH-criteria for sarcopenia predict 15-year mortality in ambulatory older men (
- Longitudinal performance assessment for predicting adverse outcomes: the added value to single time point Timed Up and Go assessment (
- 2014
- Relation of adrenal-derived steroids with bone maturation, mineral density and geometry in healthy prepubertal and early pubertal boys (
- Associations of sex steroids with bone maturation, bone mineral density, bone geometry, and body composition: a cross-sectional study in healthy male adolescents (
- The association of frailty with serum 25-hydroxy vitamin D in older men (
- Cross-sex hormone therapy in trans persons is safe and effective at short-time follow-up: results from the European Network for the Investigation of Gender Incongruence (
- Frailty and health-related quality of life in ambulatory older men (
- Short- and long-term clinical skin effects of testosterone treatment in trans men (
- 2013
- Low bone mass is prevalent in male-to-female transsexual persons before the start of cross-sex hormonal therapy and gonadectomy (
- Physical function measurements predict mortality in ambulatory older men (
- Physical function measurements predict mortality in ambulatory older men (
- Associations between single nucleotide polymorphisms in thyroid hormone transporter genes (MCT8, MCT10 and OATP1C1) and circulating thyroid hormones (
- Heredity and lifestyle in the determination of between-subject variation in thyroid hormone levels in euthyroid men (
- Physical function measurements predict mortality in ambulatory older men (
- Long-term evaluation of donor-site morbidity after radial forearm flap phalloplasty for transsexual men (
- 2012
- Bone mass, bone geometry, and body composition in female-to-male transsexual persons after long-term cross-sex hormonal therapy (
- Comparative bone status assessment by dual energy X-ray absorptiometry, peripheral quantitative computed tomography and quantitative ultrasound in adolescents and young adults with cystic fibrosis (
- Body composition and metabolic parameters are associated with variation in thyroid hormone levels among euthyroid young men (
- 2011
- Quality of life and sexual health after sex reassignment surgery in transsexual men (
- Evaluation of voice in female-to-male transsexuals (
- 2010
- Can zoledronic acid treatment improve bone strength parameters assessed by PQCT: a pilot study (
- 2009
- Polymorphisms of the SHBG gene contribute to the interindividual variation of sex steroid hormone blood levels in young, middle-aged and elderly men (
- Anthropometric and skeletal phenotype in men with idiopathic osteoporosis and their sons is consistent with deficient estrogen action during maturation (
- Prevalence of Low Bone Mass in Relation to Estrogen Treatment and Body Composition in Male-to-Female Transsexual Persons (
- 2008
- Body composition, volumetric and areal bone parameters in male-to-female transsexual persons (
- On the detection of pleiotropic QTLs in non-random and large pedigrees: empirical evaluation of different multi-trait linkage tests (
- Genome-wide linkage screen of bone mineral density (BMD) in European pedigrees ascertained through a male relative with low BMD values: Evidence for quantitative trait loci on 17q21-23, 11q12-13, 13q12-14, and 22q11 (
- 2007
- Fore-arm speed of sound in cystic fibrosis patients: correlation with bone mineral density and cortical wall thickness assessed using pQCT (
- 2006
- Contribution of serum insulin-like growth factor I (IGF-I) and the cytosine-adenosine repeat polymorphism of the IGF-I gene to bone homeostasis in elderly men (
- 2002
- Site- and sex-specific familial effect in the determination of bone mineral density in osteoporotic men and their relatives (
- Prevalence of sex steroid deficiency in men receiving systemic glucocorticoids (
- Prediction of bone mineral density by estrogen precursors, estradiol, SHBG and BMI in elderly women at risk for osteoporotic fractures (
- 2001
- Inverse association between bone turnover rate and bone mineral density in community-dwelling men > 70 years of age: No major role of sex steroid status (
- Free of bioavailable estradiol is a determinant of bone loss in community-dwelling elderly men: A longitudinal study. (
- 1999
- Limited clinical utility of a self-evaluating risk assessment scale for postmenopausal osteoporosis: Lack of predictive value of lifestyle-related factors. (